PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW145697View Pathway |
drug action
Sitaxentan Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:25 Last Updated: October 07, 2023 at 16:25 |
PW176176View Pathway |
Sitaxentan Predicted Metabolism Pathway newHomo sapiens
Metabolites of Sitaxentan are predicted with biotransformer.
|
Creator: Omolola Created On: November 30, 2023 at 10:10 Last Updated: November 30, 2023 at 10:10 |
PW124281View Pathway |
signaling
Sjogren PathwayHomo sapiens
|
Creator: Guest: Anonymous Created On: October 25, 2020 at 21:29 Last Updated: October 25, 2020 at 21:29 |
PW121769View Pathway |
disease
Smith-Lemli-Opitz Syndrome (SLOS)Mus musculus
The autosomal recessive disorder Smith-Lemli-Opitz Syndrome (SLOS; SLO Syndrome; RSH; Rutledge Lethal Multiple Congenital Anomaly, Syndrome; Polydactyly, Sex Reversal, Renal Hypoplasia, and Unilobar Lung; Lethal Acrodysgenital Syndrome) is characterized by disordered steroid biosynthesis. It results from a mutation in the DHCR7 gene coding for the enzyme sterol delta-7-reducatase. This enzyme catalyzes the production of cholesterol by reducing the C7-C8 double bond of 7-dehydrocholesterol (7-DHC). SLOS causes the accumulation of 7-dehydrocholesterol and 8-dehydrocholesterol, and a decrease of cholesterol in plasma; and 3-methylglutaconic acid in urine. All patients with SLOS have mental retardation, and symptoms include ambiguous genitalia, hypotonia, microcephaly, syndactyly, limb abnormalities and deformities and polydactyly.
|
Creator: Ana Marcu Created On: September 10, 2018 at 15:49 Last Updated: September 10, 2018 at 15:49 |
PW121994View Pathway |
disease
Smith-Lemli-Opitz Syndrome (SLOS)Rattus norvegicus
The autosomal recessive disorder Smith-Lemli-Opitz Syndrome (SLOS; SLO Syndrome; RSH; Rutledge Lethal Multiple Congenital Anomaly, Syndrome; Polydactyly, Sex Reversal, Renal Hypoplasia, and Unilobar Lung; Lethal Acrodysgenital Syndrome) is characterized by disordered steroid biosynthesis. It results from a mutation in the DHCR7 gene coding for the enzyme sterol delta-7-reducatase. This enzyme catalyzes the production of cholesterol by reducing the C7-C8 double bond of 7-dehydrocholesterol (7-DHC). SLOS causes the accumulation of 7-dehydrocholesterol and 8-dehydrocholesterol, and a decrease of cholesterol in plasma; and 3-methylglutaconic acid in urine. All patients with SLOS have mental retardation, and symptoms include ambiguous genitalia, hypotonia, microcephaly, syndactyly, limb abnormalities and deformities and polydactyly.
|
Creator: Ana Marcu Created On: September 10, 2018 at 15:51 Last Updated: September 10, 2018 at 15:51 |
PW127199View Pathway |
disease
Smith-Lemli-Opitz Syndrome (SLOS)Homo sapiens
The autosomal recessive disorder Smith-Lemli-Opitz Syndrome (SLOS; SLO Syndrome; RSH; Rutledge Lethal Multiple Congenital Anomaly, Syndrome; Polydactyly, Sex Reversal, Renal Hypoplasia, and Unilobar Lung; Lethal Acrodysgenital Syndrome) is characterized by disordered steroid biosynthesis. It results from a mutation in the DHCR7 gene coding for the enzyme sterol delta-7-reducatase. This enzyme catalyzes the production of cholesterol by reducing the C7-C8 double bond of 7-dehydrocholesterol (7-DHC). SLOS causes the accumulation of 7-dehydrocholesterol and 8-dehydrocholesterol, and a decrease of cholesterol in plasma; and 3-methylglutaconic acid in urine. All patients with SLOS have mental retardation, and symptoms include ambiguous genitalia, hypotonia, microcephaly, syndactyly, limb abnormalities and deformities and polydactyly.
|
Creator: Ray Kruger Created On: November 07, 2022 at 14:40 Last Updated: November 07, 2022 at 14:40 |
PW000095View Pathway |
disease
Smith-Lemli-Opitz Syndrome (SLOS)Homo sapiens
The autosomal recessive disorder Smith-Lemli-Opitz Syndrome (SLOS; SLO Syndrome; RSH; Rutledge Lethal Multiple Congenital Anomaly, Syndrome; Polydactyly, Sex Reversal, Renal Hypoplasia, and Unilobar Lung; Lethal Acrodysgenital Syndrome) is characterized by disordered steroid biosynthesis. It results from a mutation in the DHCR7 gene coding for the enzyme sterol delta-7-reducatase. This enzyme catalyzes the production of cholesterol by reducing the C7-C8 double bond of 7-dehydrocholesterol (7-DHC). SLOS causes the accumulation of 7-dehydrocholesterol and 8-dehydrocholesterol, and a decrease of cholesterol in plasma; and 3-methylglutaconic acid in urine. All patients with SLOS have mental retardation, and symptoms include ambiguous genitalia, hypotonia, microcephaly, syndactyly, limb abnormalities and deformities and polydactyly.
|
Creator: WishartLab Created On: August 01, 2013 at 15:52 Last Updated: August 01, 2013 at 15:52 |
PW126929View Pathway |
physiological
Smooth muscle contraction - relaxationHomo sapiens
|
Creator: Guest: Anonymous Created On: May 16, 2022 at 05:03 Last Updated: May 16, 2022 at 05:03 |
PW132336View Pathway |
Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) Drug MetabolismHomo sapiens
Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 20:58 Last Updated: September 21, 2023 at 20:58 |
PW146755View Pathway |
drug action
Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:57 Last Updated: October 07, 2023 at 18:57 |